Lu et al. [29] prepared PLLA NCs without stabilizer and analyzed the release of BSA from PLLA NCs. When PLLA with molecular weights of 16 and 51kD is used in the preparation of NCs, the model reveals that kS and koff remain see more nearly unchanged. However, ΔG decreases from 0.41 to −3.3

× 10−21J, suggesting that high molecular weight PLLA enhances BSA-excipient interactions Inhibitors,research,lifescience,medical and thus the entrapment of BSA molecules in the carrier. Consistent with the fact that the two types of PLLA NCs release BSA at a comparable rate in the steady-state release phase, an increase in the molecular weights of PLLA induces slight changes in the rate constants of disassociation. Beside particle size and excipient composition, the surface charge of carriers can profoundly influence the in

vivo delivery and accumulation of drug at the site of action. Calvo et al. [27] reported that the coating of PECL NCs using the cationic PLL significantly improves the corneal penetration of indomethacin Inhibitors,research,lifescience,medical and thus its ocular bioavailability. Moreover, the PLL coating does not alter the release profiles of indomethacin. Indeed, the simulation shows slight or little change in all three model parameters. 3.3. Drug Release from Nanoparticles Compared to liposomes, NPs may possess improved stability. Nevertheless, various mechanisms Inhibitors,research,lifescience,medical need to be explored for enhancing NP-drug interaction and achieving sustained release. For instance, NPs prepared from poly(lactic acid) (PLA), poly(glycolic

acid) (PGA), and PLGA may release hydrophobic drug in a sustained manner, due to the strong hydrophobic interaction between NPs and drug molecules [12, 13]. The sustained release of the Inhibitors,research,lifescience,medical encapsulated Inhibitors,research,lifescience,medical drug may be regulated by matrix degradation, which, in turn, can be adjusted by changing the lactide/glycolide ratio and molecular weight [9, 12]. To encapsulate a hydrophilic drug, additives capable of converting hydrophilic molecules into hydrophobic ones via ion pairing can be included [9]. Additives such as metal ions and charged polymers may form complexes with drug molecules and/or NPs [9–11]. As a result, isothipendyl the ionic strength of the release medium may potentially affect release kinetics of an encapsulated drug [10]. In this study (Figures 4(b)–4(f)), we use the model to analyze the influences of charged additives [11], the release medium [10], the matrix composition and molecular weight [9, 12], and the particle size [13] on release profiles of various drugs from NPs. For comparison, the rapid release of telmisartan (TEL) from mesoporous silica nanoparticles (MSNPs), in which none of the mechanisms given above is explored [30], is also simulated (Figure 4(a)). Parameter estimates for the simulations are listed in Table 2. Table 2 Parameter estimates for simulations in Figure 4.